A single challenge in vaccine advancement is financial: A lot of the conditions most demanding a vaccine, which include HIV, malaria and tuberculosis, exist principally in lousy nations around the world. Pharmaceutical companies and biotechnology firms have small incentive to build vaccines for these diseases because There may be little revenue pro